Generalizability in two clinical trials of Lyme disease

@article{Cameron2006GeneralizabilityIT,
  title={Generalizability in two clinical trials of Lyme disease},
  author={Daniel J. Cameron},
  journal={Epidemiologic Perspectives & Innovations},
  year={2006},
  volume={3},
  pages={12 - 12}
}
OBJECTIVE To examine the generalizability of two National Institutes of Health (NIH)-funded double-blind randomized placebo-controlled clinical trials in patients with chronic Lyme disease and to determine whether selection factors resulted in the unfavorable outcomes. DESIGN Epidemiologic review of the generalizability of two trials conducted by Klempner et al. This paper considers whether the study group was representative of the general chronic Lyme disease population. RESULTS In their… CONTINUE READING
1
Twitter Mention

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

Chronic neurologic manifestations of Lyme disease.

  • The New England journal of medicine
  • 1991
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

A comparison of two treatment regimens of ceftriaxone in late Lyme disease

  • Wiener klinische Wochenschrift
  • 2005
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Tetracycline therapy for chronic Lyme disease.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1997
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL